Treatment of an acquired coagulopathy with recombinant activated factor VII in a damage-control patient

被引：9
|
作者：
Holcomb, JB [1 ]
Hoots, K
Moore, FA
机构：
[1] Univ Texas, Hlth Sci Ctr, Dept Trauma & Crit Care, Houston, TX 77030 USA
[2] Uniformed Serv Univ Hlth Sci, Bethesda, MD 20814 USA
[3] Univ Texas, Hlth Sci Ctr, Dept Pediat Hematol, Houston, TX 77030 USA
[4] Univ Texas, Hlth Sci Ctr, Dept Surg, Houston, TX 77030 USA
来源：
MILITARY MEDICINE | 2005年 / 170卷 / 04期
关键词：
D O I：
10.7205/MILMED.170.4.287
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
Recombinant activated factor VII is commonly used for the treatment of hemophiliac patients with inhibitors and has been studied for use in trauma. We report the use of recombinant activated factor VII for a male patient who was injured in a motor vehicle accident. We also summarize the animal studies and clinical trials that have been reported.
引用
收藏
页码：287 / 290
页数：4
相关论文
共 50 条
  • [1] Use of recombinant activated factor VII to treat the acquired coagulopathy of trauma
    Holcomb, JB
    [J]. JOURNAL OF TRAUMA-INJURY INFECTION AND CRITICAL CARE, 2005, 58 (06): : 1298 - 1303
  • [2] Treatment of a severely bleeding patient without preexisting coagulopathy with activated recombinant factor VII
    Vlot, AJ
    Ton, E
    Mackaay, AJC
    Kramer, MHH
    Gaillard, CAJM
    [J]. AMERICAN JOURNAL OF MEDICINE, 2000, 108 (05): : 421 - 423
  • [3] The use of recombinant activated factor VII in congenital and acquired factor VII deficiencies
    Muleo, G
    Santoro, R
    Iannaccaro, PG
    Papaleo, P
    Leo, F
    [J]. BLOOD COAGULATION & FIBRINOLYSIS, 1998, 9 (04) : 389 - 390
  • [4] Use of recombinant activated factor VII in patients with severe coagulopathy and bleeding
    Ho, AMH
    Dion, PW
    Karmakar, MK
    [J]. ANESTHESIOLOGY, 2003, 98 (04) : 1025 - 1026
  • [5] Treatment of severe coagulopathy after gunshot injury to the head using recombinant activated factor VII
    Aiyagari, V
    Menendez, JA
    Diringer, MN
    [J]. JOURNAL OF CRITICAL CARE, 2005, 20 (02) : 176 - 179
  • [6] PERIOPERATIVE MANAGEMENT OF HEMIARTHROPLASTY OF THE HIP WITH RECOMBINANT ACTIVATED FACTOR VII IN A PATIENT WITH ACQUIRED HAEMOPHILIA
    Thachil, V.
    Punekar, A.
    Walker, C.
    Martlew, J.
    Toh, C. H.
    [J]. HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2008, 93 : 422 - 422
  • [7] TREATMENT TACTICS FOR A PATIENT WITH ACQUIRED HEMOPHILIA: CONTINUOUS INFUSION OF RECOMBINANT ACTIVATED COAGULATION FACTOR VII AND THE INHIBITOR ERADICATION
    Galstyan, G. M.
    Nalbandyan, S. A.
    Sabirov, K. R.
    Soboleva, O. A.
    Kovalenko, A., V
    Gorgidze, L. A.
    Zorenko, V. Y.
    [J]. GEMATOLOGIYA I TRANSFUZIOLOGIYA, 2022, 67 (02): : 282 - 294
  • [8] Magic in a bottle? A Focused review of factor concentrates for the intraoperative treatment of acquired coagulopathy - Fibrinogen concentrate, prothrombin complex concentrate, and recombinant activated factor VII
    Zabida, Amir
    Bartoszko, Justyna
    Karkouti, Keyvan
    [J]. BEST PRACTICE & RESEARCH-CLINICAL ANAESTHESIOLOGY, 2023, 37 (04) : 527 - 536
  • [9] Recombinant activated factor VII (rFVIIa) for the treatment of bleeding secondary to acquired factor VIII inhibitor
    Baudo, F
    Gaidano, G
    Carloni, MT
    Coppola, A
    Fariciotti, A
    Iorio, A
    Marietta, M
    Marongiu, F
    Mazzucconi, MG
    Miraglia, E
    Schiavoni, M
    Schinco, PC
    [J]. BLOOD, 2002, 100 (11) : 100B - 100B
  • [10] CLINICAL EXPERIENCES WITH RECOMBINANT ACTIVATED FACTOR VII IN ACQUIRED HAEMOPHILIA A
    Sottilotta, G.
    Luise, F.
    Nicolo, G. M.
    Oriana, V.
    Piromalli, A.
    [J]. HAEMOPHILIA, 2021, 27 : 55 - 55
12345